![Charles M. Perou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles M. Perou
Fondateur chez GeneCentric Therapeutics, Inc.
Postes actifs de Charles M. Perou
Sociétés | Poste | Début | Fin |
---|---|---|---|
GeneCentric Therapeutics, Inc.
![]() GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - | - |
Fondateur | 01/01/2011 | - | |
The University of North Carolina at Charlotte | Corporate Officer/Principal | 01/01/2000 | - |
Historique de carrière de Charles M. Perou
Formation de Charles M. Perou
Bates College | Undergraduate Degree |
University of Utah | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Director/Board Member | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
GeneCentric Therapeutics, Inc.
![]() GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
- Bourse
- Insiders
- Charles M. Perou
- Expérience